UnitedHealth Group Incorporated – Consensus Indicates Potential 9.1% Upside

DirectorsTalk Interviews

UnitedHealth Group Incorporated with ticker code (UNH) have now 24 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 632 and 360 and has a mean target at 573.79. Given that the stocks previous close was at 525.86 this now indicates there is a potential upside of 9.1%. There is a 50 day moving average of 528.68 and the 200 day MA is 498.92. The market cap for the company is $493,424m. Visit the company website at: https://www.unitedhealthgroup.com

The potential market cap would be $538,397m based on the market concensus.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

Share on:
Find more news, interviews, share price & company profile here for:

    Boku partners with Canva to boost access in Asia and Europe via localised payments

    Boku has announced a strategic partnership with Canva to expand the design platform’s reach across Asia and Europe through localised payment methods. The collaboration has already launched Vietnam’s MoMo digital wallet on Canva, with more integrations planned for 2025, aiming to make the platform more accessible in regions where card usage is low.

    Jubilee Metals to sell SA chrome and PGM assets for US$90m

    Jubilee Metals has issued a circular outlining plans to sell its Chrome and PGM Operations in South Africa to One Chrome (Pty) Ltd for up to US$90 million.

    Real Estate Credit Investments posts 2025 AGM circular

    Real Estate Credit Investments has issued its 2025 AGM circular and proxy form to shareholders. The meeting will take place on 17 September 2025 at East Wing, Trafalgar Court, St. Peter Port, Guernsey, with documents available via the National Storage Mechanism.

    Nuformix applies for US Orphan Drug Designation for NXP002 in IPF

    Nuformix has submitted an application to the US FDA for Orphan Drug Designation for tranilast, the active ingredient in its NXP002 inhaled therapy for idiopathic pulmonary fibrosis.

    Dekel Agri-Vision sees record cashew output, higher palm oil prices

    Dekel Agri-Vision has announced a July 2025 update, highlighting record monthly raw cashew nut processing of 533 tonnes at its Tiebissou plant, up 423% from July 2024.

    Diversified Energy delivers strong H1 2025 with Carlyle partnership boost

    Diversified Energy Company posted first-half 2025 results in line with expectations, delivering strong production growth, improved financial metrics, and $152 million in adjusted free cash flow

      Search

      Search